Page last updated: 2024-08-21

benzoxazoles and a-Synucleinopathies

benzoxazoles has been researched along with a-Synucleinopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adam, GC; Burlein, C; Cosden, M; Drolet, RE; Flick, R; Fraley, M; Gretzula, CA; Hatcher, NG; Jinn, S; Kandebo, M; Lemaire, W; Ma, L; Marcus, JN; Minnick, C; Mulhearn, J; Smith, SM; Toolan, D; Watt, ML; Yao, L	1

Other Studies

1 other study(ies) available for benzoxazoles and a-Synucleinopathies

Article	Year
A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy. Neurobiology of disease, 2021, Volume: 159 Topics: alpha-Synuclein; Animals; Benzoxazoles; Dopaminergic Neurons; Glucosylceramidase; Glucosyltransferases; Glycosphingolipids; In Vitro Techniques; Lysosomes; Mice; Neurons; Parkinson Disease; Primary Cell Culture; Protein Aggregates; Rats; Synucleinopathies	2021

Article

Year

A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.

Neurobiology of disease, 2021, Volume: 159

Topics: alpha-Synuclein; Animals; Benzoxazoles; Dopaminergic Neurons; Glucosylceramidase; Glucosyltransferases; Glycosphingolipids; In Vitro Techniques; Lysosomes; Mice; Neurons; Parkinson Disease; Primary Cell Culture; Protein Aggregates; Rats; Synucleinopathies

2021